Output details
12 - Aeronautical, Mechanical, Chemical and Manufacturing Engineering
University College London
Scale-up of human embryonic stem cell culture using a hollow fibre bioreactor
Cell therapies require the manufacturing of cells in sufficient quantity for routine clinical practice. The current method of growing cells on the surface of a flat-sided bottle is pragmatically acceptable for clinical proof of concept but not for scaled Good Manufacturing Practice (GMP) production. Collaborating with Beckman Coulter (now acquired by Terumo) we were the first to demonstrate that even highly delicate human embryonic stem cells can be successfully grown in a closed system of parallel hollow fibres. Terumo is currently using our data to support development of their next generation GMP hollow fibre bioreactors (Dr Stefano Baila, stefano.baila@terumobct.com).